Back
ESC2025 Premium Access

Cardiovascular risk profiling in allogenic hematopoietic stem cell transplantation survivors

Session: Cardio-oncology challenges
Topic: Stratification, Prevention and Monitoring
Speaker: Mr M. Mutti (Basel, CH)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Mikko Emilio Mutti

Cardiovascular Research Institute Basel, Basel (Switzerland)
0 follower

4 more presentations in this session

MyD-88/NLRP-3 inhibition by dapagliflozin protects against anthracycline and trastuzumab cardiotoxicity in preclinical models

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Biomarker and imaging characterisation of inflammatory atheroma in patients receiving immunotherapy and angiogenesis inhibitors (BIOCAPRI): a prospective study using positron emission tomography

Speaker: Doctor S. Rankin (Glasgow, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning

Speaker: Doctor D. Chen (New Taipei City, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Surveillance of left ventricular function among asymptomatic cancer survivors

Speaker: Doctor C. Soh (Melbourne, AU)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardio-oncology challenges

Speakers: Mr M. Mutti, Doctor N. Maurea, Doctor S. Rankin, Doctor D. Chen, Doctor C. Soh
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources